Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 9873-9880

  Zufferey, Romain ^a   Dull, Thomas ^b   Mandel, Ronald J ^b   Bukovsky, Anatoly ^b   Quiroz, Dulce ^b   Naldini, Luigi ^b   Trono, Didier ^a,c  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b CELL GENESYS INC   (United States)

^c CMU ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; VIRUS RNA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRINAE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TATA BOX;

EID: 0031743608     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.9873-9880.1998     Document Type: Article

References (31)

1. Berlingieri, M. T., G. Manfioletti, M. Santoro, A. Bandiera, R. Visconti, V. Giancotti, and A. Fusco. 1995. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol. Cell. Biol. 15:1545-1553.
2. Blömer, U., L. Naldini, T. Kafri, D. Trono, I. M. Verma, and F. H. Gage. 1997. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71:6641-6649.
3. Chen, B. F., C. L. Hsieh, D. S. Chen, and L. H. Hwang. 1992. Improved gene expression by a U3-based retroviral vector. Biochem. Biophys. Res. Commun. 184:330-337.
4. Cullen, B. R., P. T. Lomedico, and G. Ju. 1984. Transcriptional interference in avian retroviruses - implications for the promoter insertion model of leukaemogenesis. Nature 307:241-245.
5. DeZazzo, J. D., J. E. Kilpatrick, and M. J. Imperiale. 1991. Involvement of long terminal repeat U3 sequences overlapping the transcription control region in human immunodeficiency virus type 1 mRNA 3′ end formation. Mol. Cell. Biol. 11:1624-1630.
6. Dougherty, J. P., and H. M. Temin. 1987. A promoter-less retroviral vector indicates that there are sequences in U3 required for 3′ RNA processing. Proc. Natl. Acad. Sci. USA 84:1197-1201.
7. Dull, T., R. Zufferey, M. Kelly, R. J. Mandel, M. Nguyen, D. Trono, and L. Naldini. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463-8471.
8. Finer, M. H., T. J. Dull, L. Quin, D. Farson, and M. R. Roberts. 1994. Kat: a high efficiency retroviral transduction system for primary human T lymphocytes. Blood 83:43-50.
9. Flamant, F., D. Aubert, C. Legrand, F. L. Cosset, and J. Samarut. 1993. Importance of 3′ non-coding sequences for efficient retrovirus-mediated gene transfer in avian cells revealed by self-inactivating vectors. J. Gen. Virol. 74:39-46.
10. Giacca, M., M. I. Gutierrez, S. Menzo, F. D'Adda Di Fagagna, and A. Falaschi. 1992. Human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. Virology 186:133-147.
11. Hafenrichter, D. G., X. Wu, S. D. Rettinger, S. C. Kennedy, M. W. Flye, and K. P. Ponder. 1994. Quantitative evaluation of liver-specific promoters from retroviral vectors after in vivo transduction of hepatocytes. Blood 84:3394-3404.
12. Hawley, R. G., L. Covarrubias, T. Hawley, and B. Mintz. 1987. Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 84:2406-2410.
13. Hwang, J. J., L. Li, and W. F. Anderson. 1997. A conditional self-inactivating retrovirus vector that uses a tetracycline-responsive expression system. J. Virol. 71:7128-7131.
14. Kafri, T., U. Blömer, D. A. Peterson, F. H. Gage, and I. M. Verma. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17:314-317.
15. Michael, N. L., L. D'Arcy, P. K. Ehrenberg, and R. R. Redfield. 1994. Naturally occuring genotypes of human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced activities. J. Virol. 68:3163-3174.
16. Nabel, G. J., S. A. Rice, D. M. Knipe, and D. Baltimore. 1988. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 239:1299-1302.
17. Naldini, L., U. Blömer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
18. Naldini, L., U. Blömer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
19. Olson, P., H. M. Temin, and R. Dornburg. 1992. Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion. J. Virol. 66:1336-1343.
20. Olson, P., S. Nelson, and R. Dornburg. 1994. Improved self-inactivating retroviral vector derived from spleen necrosis virus. J. Virol. 68:7060-7066.
21. Proudfoot, N. J. 1986. Transcriptional interference and termination between duplicated alpha-globin gene constructs suggests a novel mechanism for gene regulation. Nature 322:562-565.
22. Sieweke, M. H., H. Tekotte, U. Jarosch, and T. Graf. 1998. Cooperative interaction of Ets-1 with USF-1 required for HIV-1 enhancer activity in T cells. EMBO J. 17:1728-1739.
23. Soriano, P., G. Friedrich, and P. Lawinger. 1991. Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells. J. Virol. 65:2314-2319.
24. Spector, D. J. 1983. The pattern of integration of viral DNA sequences in the adenovirus 5-transformed human cell line 293. Virology 130:533-538.
25. Trono, D., and D. Baltimore. 1990. A human cell factor is essential for HIV-1 Rev action. EMBO J. 9:4155-4160.
26. Valsamakis, A., S. Zeichner, S. Carswell, and J. C. Alwine. 1991. The human immunodeficiency virus type 1 polyadenylation signal: a 3′ long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylation. Proc. Natl. Acad. Sci. USA 88:2108-2112.
27. Valsamakis, A., N. Schek, and J. C. Alwine. 1992. Elements upstream of the AAUAAA within the human immunodeficiency virus polyadenylation signal are required for efficient polyadenylation in vitro. Mol. Cell. Biol. 12:3699-3705.
28. Wu, X., J. Holschen, S. C. Kennedy, and K. P. Ponder. 1996. Retroviral vector sequences may interact with some internal promoters and influence expression. Hum. Gene Ther. 7:159-171.
29. Yee, J. K., J. C. Moores, D. J. Jolly, J. A. Wolff, J. G. Respress, and T. Friedmann. 1987. Gene expression from transcriptionally disabled retroviral vectors. Proc. Natl. Acad. Sci. USA 84:5197-5201.
30. Yu, S. F., T. von Ruden, P. W. Kantoff, C. Graber, M. Seiberg, U. Ruther, W. F. Anderson, and E. Gilboa. 1986. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83:3194-3198.
31. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.